Biodesix_lockup_r_rgb (2).jpg
Biodesix To Present Data at SITC Annual Meeting
25 oct. 2017 10h00 HE | Biodesix, Inc.
BOULDER, Colo., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Biodesix will conduct an oral presentation on immunotherapy biomarkers in addition to presenting data from two separate studies at the SITC 2017...
SAB logo
Introducing The Society For Advanced Bronchoscopy TAMPA, Fla., Sept. 28, 2017 (GLOBE NEWSWIRE) -- The Society for Advanced Bronchoscopy announced its inception and plans for its first annual meeting today, citing the need to “promote and support...
Biodesix_lockup_r_rgb (2).jpg
Study Published In Managed Care Regarding Prognostic and Cancer-Care Planning Value of Biodesix’s VeriStrat® Proteomic Test
20 sept. 2017 11h17 HE | Biodesix, Inc.
BOULDER, Colo., Sept. 20, 2017 (GLOBE NEWSWIRE) -- Findings published in the peer-reviewed journal Managed Care showed that prognostic information provided by the Biodesix® VeriStrat test can...
Biodesix_lockup_r_rgb (2).jpg
Interim Results from Biodesix® Study Indicate That VeriStrat Testing Impacts Treatment Decisions Across All Stages of Non-Small Cell Lung Cancer
15 sept. 2017 11h55 HE | Biodesix, Inc.
BOULDER, Colo., Sept. 15, 2017 (GLOBE NEWSWIRE) -- Interim analysis of a new study examining the impact of VeriStrat testing on treatment decisions in patients with non-small cell lung cancer...
Biodesix_lockup_r_rgb (2).jpg
Biodesix Presents Cell-free DNA Process Optimization for Liquid Biopsy Test
08 août 2017 13h17 HE | Biodesix, Inc.
BOULDER, Colo., Aug. 08, 2017 (GLOBE NEWSWIRE) -- In two separate talks, Biodesix scientists presented information on further development and improvement of laboratory processes used for the...
Biodesix_lockup_r_rgb (2).jpg
Lung Cancer: VeriStrat® Test Identifies Patients with Squamous Cell Carcinoma of the Lung Who Are More Likely to Have Improved Survival on Afatinib Therapy
10 juil. 2017 13h09 HE | Biodesix, Inc.
BOULDER, Colo., July 10, 2017 (GLOBE NEWSWIRE) -- Clinical findings published in the peer reviewed journal Lung Cancer show that the Biodesix® VeriStrat test is prognostic for outcomes in patients...
Biodesix_lockup_r_rgb (2).jpg
Biodesix® and Positive Bioscience Announce Partnership to Bring Cancer Tests to India
12 juin 2017 12h37 HE | Biodesix, Inc.
BOULDER, Colo., June 12, 2017 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Boulder, CO, USA) and Positive Bioscience (Mumbai, India) announced today that they have entered into an agreement where Positive...
Biodesix_lockup_r_rgb (2).jpg
New Study Shows Advanced Diagnostic Tests, Including the VeriStrat® Test, Can Help Physicians Improve Cancer Care Planning and Reach Quality Measures For Patients
22 mai 2017 13h31 HE | Biodesix, Inc.
BOULDER, Colo., May 22, 2017 (GLOBE NEWSWIRE) -- Today, Biodesix®, Inc. will present the results of a new study demonstrating that VeriStrat testing and other tools can help physicians improve...
Biodesix_lockup_r_rgb (2).jpg
Biodesix Presents Data From Three Studies at AACR Annual Meeting
05 avr. 2017 08h00 HE | Biodesix, Inc.
BOULDER, Colo., April 05, 2017 (GLOBE NEWSWIRE) -- Biodesix is presenting three studies that support the company’s multi-omic capabilities and provide insight into the biology of classifiers...
Biodesix_lockup_r_rgb (2).jpg
New Data Show Biodesix’s VeriStrat® Test is Cost-Saving, Improves Survival and Quality of Life in Advanced Lung-Cancer Patients
03 avr. 2017 13h08 HE | Biodesix, Inc.
BOULDER, Colo., April 03, 2017 (GLOBE NEWSWIRE) -- Biodesix®, Inc. announced today new data demonstrating that use of the VeriStrat® test in patients with advanced non-small cell lung cancer (NSCLC)...